Drugs / LSD
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT03321136 Comparator | Nov 2017 → Jul 2019 | — | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LSD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03321136 ↗ |
| Action | Activate | “LSD potently stimulates the 5-HT2A receptor” NCT03321136 ↗ |
| Route | Oral | “0.025 mg LSD per os, single dose” NCT03321136 ↗ |